Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PFIZER, INC.

(PFE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Pfizer : Goldman Sachs Adjusts Pfizer's Price Target to $48 From $44, Maintains Neutral Rating

07/29/2021 | 11:50am EDT


ę MT Newswires 2021
All news about PFIZER, INC.
05:22pPFIZER : CDC panel recommends Pfizer booster shot for those over 65, high-risk groups
AQ
05:14pHealthcare Shares Gain as Covid-19 Developments Continue -- Healthcare Roundup
DJ
04:56pU.S. CDC advisers back COVID-19 booster shots for those 65 and older, not for high-risk..
RE
04:30pU.S. CDC advisers recommend COVID-19 vaccine boosters for 65 and older, high risk
RE
04:12pPFIZER : CDC Advisory Unanimously Recommends Pfizer/BioNTech COVID Booster For Adults 65 Y..
MT
03:51pPFIZER : Keeps Quarterly Cash Dividend at $0.39 a Share, Payable Dec. 6 to Shareholders of..
MT
12:12pMODERNA : EU drugs regulator to decide on Pfizer vaccine booster in early October
RE
12:08pPFIZER : US sets the stage for COVID booster shots for millions
AQ
10:18aVC DAILY : Biotechs Seek New Skill Set From -2-
DJ
10:03aPFIZER : Invites Public to View and Listen to Webcast of Pfizer November 2 Conference Call..
BU
More news
Analyst Recommendations on PFIZER, INC.
More recommendations
Financials (USD)
Sales 2021 81 111 M - -
Net income 2021 18 438 M - -
Net Debt 2021 28 980 M - -
P/E ratio 2021 13,1x
Yield 2021 3,57%
Capitalization 246 B 246 B -
EV / Sales 2021 3,40x
EV / Sales 2022 4,01x
Nbr of Employees 78 500
Free-Float 59,3%
Chart PFIZER, INC.
Duration : Period :
Pfizer, Inc. Technical Analysis Chart | PFE | US7170811035 | MarketScreener
Technical analysis trends PFIZER, INC.
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 20
Last Close Price 44,19 $
Average target price 45,08 $
Spread / Average Target 2,01%
EPS Revisions
Managers and Directors
Albert Bourla Chairman, Chief Executive & Operating Officer
Frank A. D'Amelio Chief Financial Officer & EVP-Global Supply
Mikael Dolsten Chief Scientific Officer & Research President
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Aida Habtezion Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
PFIZER, INC.19.32%246 414
JOHNSON & JOHNSON4.16%431 543
ROCHE HOLDING AG10.05%322 644
NOVO NORDISK A/S50.62%232 291
ELI LILLY AND COMPANY35.22%206 972
ABBVIE INC.-0.69%188 045